Avstera Therapeutics: Funding, Investors & Team (Oct 2026)
A specialty oncology-focused biopharmaceutical company with a large pipeline of novel small molecules and biologics that focuses on the science underpinning tumor biology while methodologically breaking down barriers and employing cutting-edge techniques to provide cancer patients with effective treatments.
Avstera Therapeutics has raised $9.6M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Oct 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avstera Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Avstera Therapeutics Funding Rounds
Avstera Therapeutics raised $4.6M in a Seed announced in Nov 2022.
11 months later, an undisclosed round of $5.0M was announced in Oct 2023.
Avstera Therapeutics Founders and Leadership Team
Contact details for the Avstera Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Avstera Therapeutics Funding Compared to Other Biotechnology Startups
Avstera Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avstera Therapeutics in Biotechnology and Philadelphia
Companies Similar to Avstera Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Avstera Therapeutics Funding FAQs
What does Avstera Therapeutics do?
A specialty oncology-focused biopharmaceutical company with a large pipeline of novel small molecules and biologics that focuses on the science underpinning tumor biology while methodologically breaking down barriers and employing cutting-edge techniques to provide cancer patients with effective treatments.
How much funding has Avstera Therapeutics raised?
Avstera Therapeutics has raised $9.6M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Oct 2023.
When did Avstera Therapeutics last raise funding?
Avstera Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Oct 2023.
Who founded Avstera Therapeutics?
FundedIQ lists Ajay Raju (Founder) at Avstera Therapeutics.
Who is the CEO of Avstera Therapeutics?
Karthik Musunuri is listed as CEO at Avstera Therapeutics.
Where is Avstera Therapeutics headquartered?
Avstera Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Avstera Therapeutics have?
Avstera Therapeutics is in the 1-10 employee band.
How does Avstera Therapeutics' funding compare to other Biotechnology startups?
Avstera Therapeutics' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Avstera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avstera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.